Effectiveness of delayed-release dimethyl fumarate on clinical disease activity and patient-reported outcomes in patients with relapsing-remitting multiple sclerosis in the real-world setting: a multicentre, open-label study (PROTEC)

被引：0
|
作者：
Berger, T. [1 ]
Brochet, B. [2 ]
Confalonieri, P. [3 ]
Giacomini, P. S. [4 ]
Montalban, X. [5 ]
Vasco Salgado, A. [6 ]
Okwuokenye, M. [7 ]
Marantz, J. L. [7 ]
Mair, W. [7 ]
机构：
[1] Univ Klin Neurol, Innsbruck, Austria
[2] Hop Pellegrin, Grp Hosp Pellegrin, Bordeaux, France
[3] Fdn IRCCS Ist Neurol Carlo Besta Milano, Milan, Italy
[4] MUHC, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada
[5] Hosp Vall dHebron Barcelona, Barcelona, Spain
[6] Hosp Prof Doutor Fernando Fonseca, EPE, Amadora, Portugal
[7] Biogen, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P634
引用
收藏
页码：298 / 299
页数：2
相关论文
共 50 条
  • [1] Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting: PROTEC
    Berger, T.
    Brochet, B.
    Brambilla, L.
    Giacomini, P. S.
    Montalban, X.
    Salgado, A. Vasco
    Su, R.
    Bretagne, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2019, 5 (04)
  • [2] Effectiveness of dimethyl fumarate on disease activity and patient-reported outcomes in French subjects with relapsing-remitting multiple sclerosis in the real-world: a subgroup analysis of PROTEC
    Brochet, B.
    Tourbah, A.
    Castelnovo, G.
    De Seze, J.
    Neau, J-P.
    Magy, L.
    Bourhis, Y.
    Bouzid, O.
    Okwuokenye, M.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 594 - 595
  • [3] Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting (vol 5, pg 1, 2019)
    Berger, T.
    Brochet, B.
    Brambilla, L.
    [J]. MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2020, 6 (02)
  • [4] Effectiveness of Delayed-release Dimethyl Fumarate on Clinical Measures and Patient reported Outcomes in Newly Diagnosed and Other Early Relapsing-Remitting Multiple Sclerosis Patients: Subgroup Analysis of PROTEC
    Berger, Thomas
    Brochet, Bruno
    Confalonieri, Paolo
    Giacomini, Paul S.
    Montalban, Xavier
    Salgado, Antonio Vasco
    Okwuokenye, Macaulay
    Fay, Monica
    Bretagne, Adrien
    [J]. NEUROLOGY, 2017, 88
  • [5] Delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis - findings from a real-world setting in Russian Federation
    Davydovskaya, M.
    Pozhidaeva, N.
    Dubchenko, E.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 934 - 935
  • [6] A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis
    Allan, Michelle
    Grant, Lindsay
    [J]. NEUROLOGY AND THERAPY, 2020, 9 (01) : 85 - 92
  • [7] DELAYED-RELEASE DIMETHYL FUMARATE DEMONSTRATED NO DIFFERENCE IN CLINICAL OUTCOMES VERSUS FINGOLIMOD IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS: RESULTS FROM THE REAL-WORLD EFFECT STUDY
    Sloane, Jacob
    Phillips, J. Theodore
    Calkwood, Jonathan
    Van der Walt, Anneke
    Min, Jinny
    Okwuokenye, Macaulay
    Taylor, Catherine
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E19 - E19
  • [8] Delayed-release Dimethyl Fumarate Demonstrated No Difference in Clinical Outcomes Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Real-World EFFECT Study
    Sloane, Jacob
    Phillips, J. Theodore
    Calkwood, Jonathan
    Van der Walt, Anneke
    Min, Jinny
    Wu, Fan
    Taylor, Catherine
    [J]. NEUROLOGY, 2018, 90
  • [9] Delayed-release dimethyl fumarate demonstrated no difference in clinical outcomes versus fingolimod in patients with relapsing-remitting multiple sclerosis: results from the real-world EFFECT study
    Sloane, J.
    Phillips, J. T.
    Calkwood, J.
    Van der Walt, A.
    Min, J.
    Okwuokenye, M.
    Taylor, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 855 - 856
  • [10] Interim Results of an Open-Label Study to Assess the Effects of Delayed-release Dimethyl Fumarate on Lymphocyte Subsets and Immunoglobulins in Patients with Relapsing-remitting Multiple Sclerosis
    Von Hehn, Christian
    Mehta, Devangi
    Prada, Claudia
    Yang, Lili
    Liu, Shifang
    Ray, Soma
    Sheikh, Sarah
    [J]. NEUROLOGY, 2017, 88
12345